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a b s t r a c t 
Redox signaling is implicated in different physiological and pathological events in the vasculature. Among the
different reactive oxygen species, hydrogen peroxide (H 2 O 2 ) is a very good candidate to perform functions
as an intracellular messenger in the regulation of several biological events. 
In this review, we summarize the main physiological sources of H 2 O 2 in the endothelium and the molecular
mechanisms by which it is able to act as a signaling mediator in the vasculature. 
c © 2014 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
Endothelial cells (ECs) line the inner surface of the cardiovascular
system acting as a natural barrier between the blood and the rest of
organs and tissues. This metabolically active monolayer organ is con-
stantly exposed to different biomechanical and biochemical stimuli
to which it responds by preserving the integrity and homeostasis of
vascular function [ 1 ]. Accumulating evidence indicates the important
role of redox signaling in the triggering and mediation of these actions.
Historically, oxidative stress and thus, the increased production of re-
active oxygen species (ROS), have been closely related with endothe-
lial dysfunction, with involvement in the pathogenesis of several car-
diovascular diseases such as hypertension, diabetes or atherosclerosis
among others [ 2 –5 ]. However, a large body of research has demon-
strated a key role for ROS as physiological regulators of intracellular
signaling pathways involved in the function of vascular endothelium
[ 6 ]. 
Redox signaling 
For many years, ROS were described as unwanted toxic products of
cellular metabolism able to cause molecular damage (including DNA,
proteins and lipids), cell and tissue dysfunction. Substantial evidences
in the past decades have proved that although high oxidant exposure
or low antioxidant defense are implicated in the pathogenesis of sev-
eral cardiovascular diseases such as atherosclerosis, hypertension or
diabetes, ROS are important signaling molecules playing an essen-
tial role in the regulation of a large variety of different cell signaling
processes [ 6 –8 ]. * Corresponding authors. Fax: + 34 911964420. 
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http://dx.doi.org/10.1016/j.redox.2014.02.005 Although the term ROS include all the chemical species derived
from the incomplete reduction of molecular oxygen (O 2 ), it is impor-
tant to mention that different redox-active species have completely
different biological properties including reactivity, half-life or lipid
solubility that have important implications in their action. Thus, the
speciﬁcity and the selectivity of the different ROS are dictated by their
chemical reactivity [ 9 ]. 
Among the different ROS, hydrogen peroxide (H 2 O 2 ) fulﬁlls the
prerequisites for serving as an intracellular messenger and acting as a
cell-signaling molecule. H 2 O 2 is a small and non-polar molecule able
to diffuse across biological membranes. It is ubiquitously produced
and its longer half-life makes it suitable to act as a second messenger
exerting prolonged effects in different signaling pathways [ 10 ]. 
To better understand the role and the effect of H 2 O 2 in redox
signaling it is critical to focus on the main sources of H 2 O 2 in the
vasculature and on the nature of this ROS as a two-electron oxidant. 
Sources of hydrogen peroxide in the endothelium 
Intracellular generation of ROS in endothelial cells both occur un-
der physiological as well as pathophysiological conditions. In the
endothelium it predominantly arises from four enzymatic systems
which include the different isoforms of NAPDH oxidases (NOXs, see
below for precisions), xanthine oxido-reductase, uncoupled endothe-
lial nitric oxide synthase (eNOS) and mitochondrial respiration com-
plexes [ 1 , 2 ]; however other sources such as the arachidonic acid
metabolizing enzymes lipoxygenase and cyclooxygenases or the cy-
tochrome P450 have been also described [ 11 ] ( Fig. 1 ). 
All these sources primarily catalyze the reduction of molecular
oxygen after the acceptance of one electron and lead to the formation
of superoxide radical anion (O 2 
•−), a ROS extremely unstable that
dismutates to H 2 O 2 either spontaneously or enzymatically catalyzed
by superoxide dismutase. Of note, some enzymes, such as glucose
oxidase or xanthine oxidase have been described to directly produce
 open access article under the CC BY-NC-ND license ( http: // creativecommons.org / 
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Fig 1. Sources of reactive oxygen species in the vascular endothelium.The major 
sources of ROS in the endothelium include NADPH oxidase isoform 4, eNOS uncoupling, 
mitochondrial respiration and xanthine oxidase. Other sources such as lipoxygenase, 
cyclooxygenase or cytochrome P450 also contribute to ROS generation in the vascular 
endothelium. 
Fig 2. Protein thiol modiﬁcations by hydrogen peroxide.H 2 O 2 induces cysteine dimer- 
ization (R–S–S–R) via the formation of the unstable intermediate sulfenic acid (R–SOH). 
Disulﬁdes can form between cysteines located in the same protein (intramolecular 
disulﬁdes), in different proteins (intermolecular disulﬁdes), or between the protein 
thiol and glutathione (S-glutathionylation). In the presence of high concentrations of 
H 2 O 2 , the sulfenic acid can become further oxidized to sulﬁnic (R–SO 2 ) or sulfonic 
(R–SO 3 ) acid. 
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m 2 O 2 by donating two electrons to oxygen [ 11 ]. In the case of the 
OX4 isoform (the most abundant NADPH oxidase in the endothe- 
ium), there is some controversy about the ROS produced. Whereas 
ome groups have described NOX4 as the only vascular homolog that 
irectly produces H 2 O 2 [ 12 ], others have proposed that the O 2 
•− pro- 
uced by NOX4 is rapidly converted to H 2 O 2 , which becomes almost 
ndetectable [ 13 ] ( Fig. 2 ). 
The main features of these enzymes are summarized as follows: 
ADPH oxidase 
In contrast to other oxidases which produce ROS as a byprod- 
ct of their catalytic function, NOX family enzymes have no known 
iosynthetic or catabolic function but synthesize ROS as their pri- 
ary function [ 14 , 15 ]. They are a family of seven trans-membrane electron transporters that catalyze the transfer of electrons across bi- 
ological membranes from the electron donor NADPH to O 2 , leading 
to the generation of O 2 
•− [ 16 ] and according to some reports H 2 O 2 
[ 12 , 17 , 18 ]. All NOX isoforms have six trans-membrane alpha helices 
with cytosolic N- and C-termini and they are differentially expressed 
and regulated in speciﬁc tissues. In endothelial cells, whereas NOX1, 
NOX2, NOX4 and NOX5 isoforms have been identiﬁed under physi- 
ological and pathophysiological conditions [ 19 ], NOX4 is by far the 
most abundant NADPH isoform [ 20 , 21 ]. In addition this isoform is 
the most distantly related member of the family. While its activity 
is dependent on p22phox, it does not require any cytosolic subunits 
such as p47phox, p67phox, p40phox or Rac, as other NOX isoforms 
do [ 22 ]. 
Xanthine oxidoreductase 
Xanthine oxidoreductase, termed as xanthine oxidase (XOR), is 
another potential source for ROS in the vasculature [ 23 ]. It is an iron–
sulfur molybdenum ﬂavoprotein enzyme that catalyzes the last steps 
of purine metabolism, the transformation of hypoxanthine and xan- 
thine to uric acid, with O 2 
•− or H 2 O 2 generation as by-products [ 24 ]. 
It exists in two forms, as xanthine dehydrogenase (XDH) and as xan- 
thine oxidase (XO) [ 25 ]. The XDH activity present in the vascular 
endothelium is converted into XO by processes including thiol oxida- 
tion and / or proteolysis. The ratio between XO and XDH in the cells 
is critical to determine the amount of ROS produced by these en- 
zymes [ 26 ]. Increases both in the expression and activity of XO have 
been related to vascular diseases [ 27 , 28 ]. In the last decade, XOR has 
been proposed as capable to produce NO • itself [ 29 , 30 ] adding a new 
essential vascular role for this enzyme in biological tissues [ 25 ]. 
Uncoupled eNOS 
NO • is produced in mammals by a family of nitric oxide synthase 
(NOS) enzymes. There are three different isoforms, two of them con- 
stitutively present (the endothelial nitric oxide synthase, eNOS or 
NOS3, and the neuronal nitric oxide synthase, nNOS or NOS1), and 
one which is inducible (iNOS or NOS2). They are all ﬂavin- and heme- 
containing enzymes that act as homodimers shuttling electrons from 
the NADPH bound at the C-terminal (reductase domain) to the N- 
terminal heme (oxidase domain), reducing O 2 and incorporating it 
into the guanidine group of l -arginine to produce l -citrulline and NO •. 
However, in the absence of cofactors ( l -arginine, tetrahydrobiopterin 
(BH4) or both) NOSs can become a source of O 2 
•− in endothelium 
[ 31 ], thus becoming “uncoupled” to their primary role of NO • syn- 
thesis. This uncoupling involves the conversion of NOS enzyme to a 
monomer which generates O 2 
•− instead of NO • [ 32 ]. Uncoupling of 
eNOS has been related to different cardiovascular diseases that concur 
with endothelial dysfunction such as atherosclerosis, hypertension, 
hypercholesterolemia or diabetes [ 33 –36 ]. 
Mitochondria 
Mitochondria represent the major intracellular source of ROS un- 
der physiological conditions. Notwithstanding, ROS production by 
mitochondria can also be enhanced by several intracellular stimuli. 
Mitochondrial ROS production is a consequence of oxidative phos- 
phorylation linked to aerobic respiration within the mitochondrial 
electron transport chain (ETC). This machinery is situated in the inner 
mitochondrial membrane and it is able to catalyze electron transfer 
using more than 80 peptides organized in four complexes [ 37 ]. The 
transfer of electrons usually leads to the formation of ATP by the ﬁfth 
complex; however, at eight different sites along the respiratory chain, 
electrons derived from NADH or FADH can directly react with oxy- 
gen and generate O 2 
•− [ 38 ]. Electron leakage from the ETC causes 
partial reduction of molecular oxygen to O 2 
•− instead of reduction 
to H 2 O. It is predicted that 1–2% of the O 2 consumed is converted 
into ROS [ 39 ]. Mitochondrial O 2 
•− dismutation by MnSOD leads to 
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Table 1 
Redox-induced effects on the vascular endothelium by MAPK. 
MAPK 
Effect of thiol 
modiﬁcation 
Effect on the 
endothelium References 
Erk1 / 2 Activation Growth and 
proliferation 
[ 59 , 60 ] 
Activation Vasodilation [ 61 ] 
Barrier 
dysfunction 
[ 62 ] 
Activation Actin 
cytoskeleton 
reorganization 
[ 63 , 64 ] 
p38 MAPK Activation Vasodilation [ 65 ] 
Activation Actin 
cytoskeleton 
reorganization 
[ 63 , 66 ] 
Activation Increase 
endothelial 
permeability 
[ 67 –69 ] 
JNK Activation Apoptosis [ 70 –72 ] 
ERK5 Activation Inhibit 
endothelial 
apoptosis 
[ 73 ] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 the formation of H 2 O 2 inside the mitochondria [ 40 ]. The tight reg-
ulation of mitochondrial ROS is essential for avoiding the accumu-
lation of ROS and oxidative damage, thus permitting the signaling
role of these species. Although the function of mitochondrial H 2 O 2
in several redox-dependent processes has been extensively reviewed
[ 41 , 42 ], data in human vasculature are very limited [ 43 ]. 
Molecular targets of hydrogen peroxide 
H 2 O 2 is a mild oxidant and hence relatively inert to most
biomolecules; nevertheless it is able to induce reversible, covalent
modiﬁcations of cysteine thiolate residues located in active and al-
losteric sites of speciﬁc proteins resulting in alterations on their ac-
tivity and function. Any protein containing a deprotonated cysteine
residue is susceptible to be oxidized by H 2 O 2 [ 44 ]; thus the sensitivity
of the protein to oxidation depends on the ionization constant (pKa)
and the local environment of the cysteine residue. Because the pKa of
the sulfhydril group of most cysteines residues is around 8.5, they are
protonated at physiological pH (Cys–SH), and so, inert to H 2 O 2 oxida-
tion. However, there are certain proteins which exhibit a lower pKa
(5,6) and thus under physiological conditions they contain cysteine
thiolate anions prone to react with H 2 O 2 under second order kinetics.
H 2 O 2 is capable of oxidizing those cysteine residues via the formation
of an unstable intermediate cysteine sulfenic acid (R–S–OH), and pro-
duce disulﬁdes (R–S–S–R) [ 45 , 46 ]. Different kinds of disulﬁde bonds
can occur depending on whether they are produced between cys-
teines within the same protein (intramolecular disulﬁde bond [ 47 ])
or between cysteines located in two different molecules producing a
homo- or hetero-dimer (intermolecular disulﬁde bond [ 48 ]). In addi-
tion, disulﬁdes can also form a mixed-disulﬁde between glutathione
and the thiol of another protein (S-glutathionylation), or with amides
to form sulfenyl amide (–SN–) [ 49 ]. Protein thiols can undergo further
two-electron oxidations by H 2 O 2 to form sulﬁnic (R–SO 2 H) or sulfonic
acid (R–SO 3 H). Once a cysteine thiol has been oxidized, it needs to be
reduced back if the signal has to be ended, and the cells are provided
by different enzymatic and non-enzymatic systems responsible for
this process. Disulﬁdes and sulfenic groups can be reduced either
by thioredoxins (TRXs) and peroxiredoxins (PRXs), while the mixed-
disulﬁde reduction is driven by glutaredoxins (GRXs) [ 50 ]. Sulﬁnic
acid groups can be reduced to sulfenic by the sulﬁredoxins (SRXs) a
family of ATP-dependent enzymes [ 51 ], and overoxidation to sulfonic
acid is considered to be biologically irreversible. 
Different proteins are capable to be modiﬁed by H 2 O 2 includ-
ing phosphatases, transcription factors, ion channels, antioxidant and
metabolic enzymes, structural proteins and protein kinases among
others [ 19 ]. In the next section, we focus on the interaction between
ROS and protein kinases that are involved in the control of the vascular
function. 
Protein kinases constitute a highly diverse group of enzymes that
alter the function of target proteins by catalyzing the phosphoryla-
tion of tyrosine, threonine, and / or serine residues [ 52 ]. A signiﬁcant
number of them are sensitive to redox signaling as they bear redox-
sensitive cysteines, either in the primary kinases themselves or in
upstream regulatory proteins. Some serine / theonine protein kinases
are modiﬁed by a direct redox modiﬁcation of susceptible cysteines.
For example protein kinase C (PKC) contains a cysteine rich domain
susceptible to oxidation [ 53 ], or the nonreceptor tyrosine kinase Src
in which endogenous H 2 O 2 oxidizes Cys-245 and Cys-487 in the ki-
nase domain resulting in the activation of the protein [ 54 ], whereas
tyrosine kinases are mainly activated in an indirect way, because of
the oxidative inactivation of the protein tyrosine phosphatases (PTP)
which control their phosphorylated state. All PTPs contain cysteine
residues in their catalytic domains that are essential for their catalytic
activity and exist as a thiolate [ 55 , 56 ]. This is frequently the mech-
anism of the ROS-mediated signal for an important group of proteinkinases, widely involved in cell signaling, the mitogen-activated pro-
tein kinases (MAPK). 
MAPKs are key components of signaling pathways triggered by
G-protein-coupled receptors, tyrosine kinase receptors, integrins and
cytokines. They are a large family of serine / theonine kinases that
requires tyrosine and threonine phosphorylation in the loop for acti-
vation [ 57 ]. They consist of four families of proteins: the extracellular
signal regulated kinase (Erk1 / 2), p38 MAPK, jun N-terminal kinase
(JNK) and the extracellular signal-regulated kinase 5 (ERK5), all of
them reported as targets of H 2 O 2 . The ERK cascade is principally in-
volved in proliferation, differentiation, growth and cell survival, JNK in
apoptosis / inﬂammation and p38 MAPK in cell motility and inﬂam-
matory responses [ 58 ]. Thus the panoply of consequences derived
from their redox regulation is quite ample. 
In Table 1 we summarize the ﬁndings regarding the activation of
MAPK by hydrogen peroxide and their role in vascular endothelial
function. 
H 2 O 2 regulation of endothelial function 
In vascular endothelial cells, ROS gained attention as impor-
tant second messengers by regulating the activity of signaling pro-
teins, enzymes and ion channels in endothelial cells. H 2 O 2 modu-
lates different aspects of endothelial cell function, including endothe-
lial cell growth and proliferation, survival, endothelium-dependent
vasorelaxation, cytoskeletal reorganization, inﬂammatory responses
and endothelium-regulated vascular remodeling, among others [ 11 ].
Whereas a modest increase and a tight controlled regulation of H 2 O 2
is essential for the maintenance of vascular homeostasis, an aber-
rant redox signaling, usually induced by an excessive production of
ROS and / or by decreases in antioxidant activity, may contribute to an
alteration in vascular function and lead to vascular disease [ 74 , 75 ]. 
We now discuss two situations where hydrogen peroxide exerts a
profound inﬂuence on endothelial cells. 
Cell growth, proliferation and angiogenesis 
Endothelial cells growth and survival are dependent on several
factors coupled to the intracellular production of O 2 
•− and H 2 O 2
[ 76 ]. For example, the growth regulating p90RSK protein [ 59 ] and
the early growth factor 1 (Egf1) [ 77 ] are activated in endothelial cells
by a redox-dependent activation of Erk1 / 2 MAPK by H 2 O 2 . More-
over, several studies have demonstrated that ROS mediate numerous
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Fig 3. Laminar shear stress regulation of vascular tone.Hydrogen peroxide activation of 
p38 MAPK is a fundamental mechanism for laminar shear stress-mediated endothelium 
vasodilation. 
a
t
g
m
[
a
d
c
w
r
o  
e
R
d
c
f
o
[
b  
t
m
c
g
t
h
n
o
t
f  
F
e
s
i
w
a
hngiogenic effects including migration, proliferation and tube forma- 
ion, through a tight regulation between H 2 O 2 and the key angio- 
enic growth factor VEGF [ 78 ]. On one side, H 2 O 2 upregulates VEGF 
RNA and protein expression and VEGF-induced VEGFR2 activation 
 59 , 79 , 80 ], inducing angiogenic-related responses. However, VEGF is 
lso able to activate one of the main sources of ROS in vascular en- 
othelial cells, NADPH oxidase [ 81 , 82 ]. 
It is important to note that these beneﬁcial effects on the vas- 
ulature are only produced by physiological concentrations of H 2 O 2 
here endothelial cell growth and angiogenesis are necessary, as in 
epairing ischemia damage [ 83 ]. However, supraphysiological levels 
f H 2 O 2 impair proliferation and / or decrease viability [ 84 , 85 ] or could
ven induce hypertrophy when diffusing to the smooth muscle [ 86 ]. 
egulation of vascular tone and vascular relaxation 
The effects of ROS on vascular tone are not uniform since they 
epend on the speciﬁc ROS molecule, its concentration, and the vas- 
ular bed that is affected among other factors [ 87 ]. In general, O 2 
•−
avors vasoconstriction because it reduces the bioavailability of nitric 
xide (NO •) by reacting with it, and by generation of peroxynitrite 
 88 , 89 ]. In contrast, H 2 O 2 induces vasodilation in different vascular 
eds, such as mesenteric [ 90 , 91 ], coronary [ 92 , 93 ] or pulmonary ar-
eries [ 94 ]. The increment of H 2 O 2 in vascular segments of transgenic 
ice with endothelial-speciﬁc NOX4 overexpression, lead to an in- 
reased vasodilation and reduced basal blood pressure [ 95 ]. H 2 O 2 
eneration contributes to the physiological regulation of the vascular 
one in different ways. It was found to be an endothelium-derived 
yperpolarizing factor [ 96 , 97 ] or an activator of the potassium chan- 
el [ 98 ], but its vasorelaxing effect has been closely related to nitric 
xide production. Indeed, H 2 O 2 leads to the stimulation of eNOS and 
he subsequent production of nitric oxide via the activation of dif- 
erent signaling pathways such as PI3K / Akt [ 61 , 99 ] and Erk1 / 2 [ 61 ].
urthermore, we have recently described the involvement of H 2 O 2 in 
NOS activation that may contribute to the protective role of laminar 
hear stress (LSS) in the vascular endothelium. We proposed a model 
n which LSS promotes the formation of signaling levels of H 2 O 2 , 
hich in turn activate p38 MAPK and eNOS, increasing NO. synthesis 
nd protection of endothelial function [ 65 ] ( Fig. 3 ). Moreover, H 2 O 2 
as been described not only as capable of activating eNOS, but also for upregulating its expression [ 100 ]. A major regulator of vasodila- 
tion in the vasculature is the protein kinase PKG1 α [ 101 ]. PKG1 α is 
also sensitive to oxidation by H 2 O 2 through the formation of a disul- 
ﬁde bond [ 102 ], accounting for the activation of the protein, and the 
related increased vasodilation independently of cGMP levels [ 103 ]. 
Conclusions 
Hydrogen peroxide acts as a signaling second messenger in the 
vasculature. Its targets in the cardiovascular system are diverse, and 
include different protein kinases, which convey a wide array of ef- 
fects to the endothelium. Although increased H 2 O 2 might result in an 
alteration of vascular reactivity and lead to toxicity and the develop- 
ment of vascular disease, signaling levels of H 2 O 2 play a key role in 
vascular function and homeostasis. 
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